Merge's Cardiology PACS named best in KLAS, hemodynamic solution ranked category leader third consecutive year

Published on:

Merge Healthcare Incorporated (Nasdaq:MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, today announced that Merge Cardio(TM) has been named Best in KLAS for the cardiology software category within the "2013 Best in KLAS: Software & Services" report. In addition, Merge Hemo(TM) has been named the Category Leader in Cardiology Hemodynamics for the third successive year.

"We're excited that not only has Merge Hemo retained its number one status as Category Leader for the third straight year, but Merge Cardio has received the Best in KLAS top honor this year, as well. We believe that both of these designations speak to our ongoing diligence in developing superior clinical solutions to meet our client's needs," said Justin Dearborn, CEO of Merge Healthcare. "What's more, we're honored to be the first vendor to receive top recognition from KLAS for both cardiology categories, and feel that this solidifies Merge's leadership status in the CVIS market."

Combined, Merge Hemo and Merge Cardio provide a seamless solution for advanced reporting and enhanced workflow. Currently running in over 500 cardiac cath labs in some of the country's largest health systems, Merge Hemo captures real-time data and documents procedural events to enable efficient workflow. Merge Cardio, implemented in over 200 organizations, is a web-enabled enterprise-level image and information system that provides a single point of entry to the patient's complete cardio record spanning all cardiac modalities.

Related Content

Concomitant ablation surgery during heart operations boosts long-term survival
Cardiologist explores why colchicine failed to help heart attack patients
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Most heart failure patients miss out on guideline-recommended palliative care
Cardiologist behind EARLY TAVR explains how proactive treatment improves patient outcomes
FDA approves Medtronic’s new all-in-one mapping and ablation system for AFib

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."